(Q36327729)

13 August 2017

1 reference

title

Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy? (English)

1 reference

13 August 2017

1 reference

Mahlon Johnson

1

1 reference

13 August 2017

Steven Toms

series ordinal

2

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Journal of Neuropathology & Experimental Neurology

13 August 2017

published in

1 reference

13 August 2017

volume

64

1 reference

13 August 2017

issue

12

1 reference

13 August 2017

page(s)

1029-1036

1 reference

Epidemiology and etiology of intracranial meningiomas: a review

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Meningioma grading: an analysis of histologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Meningioma: current treatment options and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Mifepristone (RU 486) treatment of meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Molecular pathogenesis of meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Epidermal growth factor receptor expression in 72 meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Expression and activation of epidermal growth factor receptors in meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

TGF alpha expression in meningioma--tumor progression and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Autocrine control of human meningioma proliferation: secretion of platelet-derived growth-factor-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Hyperexpression of mitogen-activated protein kinase in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Identification of phospholipase C-gamma1 as a mitogen-activated protein kinase substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Smads as transcriptional co-modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Epidermal growth factor receptor inhibition strategies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Farnesyl transferase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Lovastatin is a potent inhibitor of meningioma cell proliferation: evidence for inhibition of a mitogen associated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.JNEN.0000189834.63951.81

10.1097/01.JNEN.0000189834.63951.81

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference